Chrystal Louis
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Chrystal U.
Louis is currently Chief Medical Officer at TScan Therapeutics, Inc. since 2024.
Formerly, Dr. Louis was Senior VP-Hematology Clinical Development at Zentalis Pharmaceuticals, Inc. from 2022 to 2024, Vice President & Head-Medical Affairs at CRISPR Therapeutics, Inc. from 2020 to 2022, and Executive Director-Myeloid Diseases at Celgene Corp.
from 2018 to 2019.
Education includes graduate and doctorate degrees from Tulane University School of Medicine and an undergraduate degree from Southwestern University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 08-04-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-03-2024 |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Corporate Officer/Principal | 01-11-2022 |
| CELGENE | Corporate Officer/Principal | 01-01-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Southwestern University
Southwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University School of Medicine
Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau